4D Molecular Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
4D Molecular Therapeutics, Inc. (FDMT) reported Basic Shares Outstanding (Weighted Average) of 70.27 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 70.27M shares, a 25.65% increase year-over-year.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 68.06M shares, a 22.10% increase year-over-year.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 63.92M shares, a 14.88% increase year-over-year.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 56.13M shares, a 1.03% increase year-over-year.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 57.93M shares, a 7.39% increase from fiscal 2024.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 53.94M shares, a 37.86% increase from fiscal 2023.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 39.13M shares, a 20.95% increase from fiscal 2022.
- 4D Molecular Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 32.35M shares, a 16.66% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 70.27M shares 10-Q · filed 2026-08-13 | 69.18M shares 10-Q · filed 2026-08-13 | 67.42M shares derived: average of 3 quarters · filed 2026-08-13 | 64.60M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 68.06M shares 10-Q · filed 2026-05-07 | 65.99M shares derived: average of 2 quarters · filed 2026-05-07 | 62.70M shares derived: average of 3 quarters · filed 2026-05-07 | 61.01M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 63.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 60.02M shares derived: average of 2 quarters · filed 2026-03-18 | 58.66M shares derived: average of 3 quarters · filed 2026-08-13 | 57.93M shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 56.13M shares 10-Q · filed 2025-11-10 | 56.03M shares derived: average of 2 quarters · filed 2026-08-13 | 55.93M shares 10-Q · filed 2025-11-10 | 55.86M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 55.93M shares 10-Q · filed 2026-08-13 | 55.84M shares 10-Q · filed 2026-08-13 | 55.77M shares derived: average of 3 quarters · filed 2026-08-13 | 55.72M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 55.74M shares 10-Q · filed 2026-05-07 | 55.69M shares derived: average of 2 quarters · filed 2026-05-07 | 55.65M shares derived: average of 3 quarters · filed 2026-05-07 | 55.56M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 55.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 55.60M shares derived: average of 2 quarters · filed 2026-03-18 | 55.49M shares derived: average of 3 quarters · filed 2026-03-18 | 53.94M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 55.55M shares 10-Q · filed 2025-11-10 | 55.42M shares derived: average of 2 quarters · filed 2025-11-10 | 53.38M shares 10-Q · filed 2025-11-10 | 50.74M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 55.28M shares 10-Q · filed 2025-08-11 | 52.28M shares 10-Q · filed 2025-08-11 | 49.14M shares derived: average of 3 quarters · filed 2025-08-11 | 47.42M shares derived: average of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | 49.27M shares 10-Q · filed 2025-05-08 | 46.07M shares derived: average of 2 quarters · filed 2025-05-08 | 44.80M shares derived: average of 3 quarters · filed 2025-05-08 | 43.18M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 42.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 42.56M shares derived: average of 2 quarters · filed 2025-02-28 | 41.15M shares derived: average of 3 quarters · filed 2025-02-28 | 39.13M shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 42.26M shares 10-Q · filed 2024-11-13 | 40.30M shares derived: average of 2 quarters · filed 2024-11-13 | 37.88M shares 10-Q · filed 2024-11-13 | 36.45M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 38.34M shares 10-Q · filed 2024-08-08 | 35.66M shares 10-Q · filed 2024-08-08 | 34.52M shares derived: average of 3 quarters · filed 2024-08-08 | 33.98M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 32.72M shares 10-Q · filed 2024-05-09 | 32.61M shares derived: average of 2 quarters · filed 2024-05-09 | 32.53M shares derived: average of 3 quarters · filed 2024-05-09 | 32.48M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 32.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 32.44M shares derived: average of 2 quarters · filed 2024-02-29 | 32.40M shares derived: average of 3 quarters · filed 2024-02-29 | 32.35M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 32.39M shares 10-Q · filed 2023-11-09 | 32.36M shares derived: average of 2 quarters · filed 2023-11-09 | 32.31M shares 10-Q · filed 2023-11-09 | 31.85M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 32.32M shares 10-Q · filed 2023-08-09 | 32.26M shares 10-Q · filed 2023-08-09 | 31.67M shares derived: average of 3 quarters · filed 2023-08-09 | 30.51M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 32.23M shares 10-Q · filed 2023-05-11 | 31.35M shares derived: average of 2 quarters · filed 2023-05-11 | 29.91M shares derived: average of 3 quarters · filed 2023-05-11 | 29.11M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 30.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 28.74M shares derived: average of 2 quarters · filed 2023-03-15 | 28.08M shares derived: average of 3 quarters · filed 2023-03-15 | 27.73M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 27.02M shares 10-Q · filed 2022-11-08 | 26.88M shares derived: average of 2 quarters · filed 2022-11-08 | 26.82M shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 26.74M shares 10-Q · filed 2022-08-11 | 26.72M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |